Navignostics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $8.57M

  • Investors
  • 7

Navignostics General Information

Description

Developer of biotechnological mechanisms designed to identify the ideal tumor analysis approaches to improve personalized diagnostics for cancer patients. The company characterizes tumors using spatial single-cell proteomics and accelerates cancer drug development by providing key insights, enabling clinicians to get treatment recommendations to help people suffering from cancer.

Contact Information

Website
www.navignostics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Tödistrasse 46a
  • Horgen
  • 8810 Zürich
  • Switzerland
+41 044
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • Tödistrasse 46a
  • Horgen
  • 8810 Zürich
  • Switzerland
+41 044

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Navignostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 09-Nov-2022 $8.57M Completed Generating Revenue
1. University Spin-Out 01-Jan-2022 Completed Generating Revenue
To view Navignostics’s complete valuation and funding history, request access »

Navignostics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
To view Navignostics’s complete cap table history, request access »

Navignostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Navignostics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bruker Corporation Minority
Think.Health Venture Capital Minority
UZH Lifesciences Fund Venture Capital Minority
Ventura BioMed Investors Venture Capital Minority
Zürcher Kantonalbank Asset Manager Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Navignostics FAQs

  • When was Navignostics founded?

    Navignostics was founded in 2022.

  • Where is Navignostics headquartered?

    Navignostics is headquartered in Zürich, Switzerland.

  • What is the size of Navignostics?

    Navignostics has 16 total employees.

  • What industry is Navignostics in?

    Navignostics’s primary industry is Discovery Tools (Healthcare).

  • Is Navignostics a private or public company?

    Navignostics is a Private company.

  • What is the current valuation of Navignostics?

    The current valuation of Navignostics is .

  • What is Navignostics’s current revenue?

    The current revenue for Navignostics is .

  • How much funding has Navignostics raised over time?

    Navignostics has raised $8.57M.

  • Who are Navignostics’s investors?

    Bruker, Think.Health, UZH Lifesciences Fund, Ventura BioMed Investors, and Zürcher Kantonalbank are 5 of 7 investors who have invested in Navignostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process